Cancer Gene Therapy:LncRNA KCNQ1OT1能够促进膀胱癌进展

2020-09-13 AlexYang MedSci原创

长非编码RNA(lncRNA)在各种癌症中具有生物学功能的特点。LncRNA KCNQ1 反向链/反义转录1 (KCNQ1OT1)被公认能够调控各种癌症,然而其在膀胱癌中的作用仍不清楚。

长非编码RNA(lncRNA)在各种癌症中具有生物学功能的特点。LncRNA KCNQ1 反向链/反义转录1 (KCNQ1OT1)被公认能够调控各种癌症,然而其在膀胱癌中的作用仍不清楚。

最近,有研究人员探究了KCNQ1OT1在膀胱癌进展中的影响和详细机制。研究结果发现,KCNQ1OT1在膀胱癌组织中的表达与正常相邻组织相比明显上调,并且KCNQ1OT1对膀胱癌细胞的恶性表型具有调控作用。此外,研究人员还验证了KCNQ1OT1可以特异性结合miR-218-5p并减少其表达。miR-218-5p过表达能够抑制膀胱癌细胞的增殖和转移,同时促进细胞凋亡。在机制方面,研究人员验证了肝素硫酸-葡萄糖胺3-磺酸转移酶3B1(HS3ST3B1)是miR-218-5p的靶基因,可以被KCNQ1OT1间接调控。

KCNQ1OT1-miR-218-5p对膀胱癌细胞增殖,迁移和细胞凋亡的影响

最后,研究人员指出,KCNQ1OT1可通过调控miR-218-5p/HS3ST3B1促进膀胱癌的进展,且有望成为膀胱癌治疗的新靶点。

原始出处:

Yongzhi Li, Benkang Shi, Fengming Dong et al. LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p/HS3ST3B1. Cancer Gene Therapy. August 2020

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1739026, encodeId=acda1e3902614, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Dec 30 21:15:55 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649939, encodeId=b7881649939cd, content=<a href='/topic/show?id=69f810441ff' target=_blank style='color:#2F92EE;'>#KCNQ1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10441, encryptionId=69f810441ff, topicName=KCNQ1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ba23947018, createdName=cqlidoudou, createdTime=Tue Dec 29 03:15:55 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049331, encodeId=358420493310b, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Nov 28 12:15:55 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755698, encodeId=1c231e55698c0, content=<a href='/topic/show?id=b41f104424d' target=_blank style='color:#2F92EE;'>#KCNQ1OT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10442, encryptionId=b41f104424d, topicName=KCNQ1OT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2efd36990859, createdName=bbwuyu_015, createdTime=Thu Apr 15 05:15:55 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301934, encodeId=cfa7130193440, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 15 02:15:55 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005738, encodeId=70c52005e38d7, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Tue Aug 24 06:15:55 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1039991, encodeId=fded103999172, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Sep 13 14:15:55 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884923, encodeId=bb5f8849233c, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Sun Sep 13 11:33:24 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1739026, encodeId=acda1e3902614, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Dec 30 21:15:55 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649939, encodeId=b7881649939cd, content=<a href='/topic/show?id=69f810441ff' target=_blank style='color:#2F92EE;'>#KCNQ1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10441, encryptionId=69f810441ff, topicName=KCNQ1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ba23947018, createdName=cqlidoudou, createdTime=Tue Dec 29 03:15:55 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049331, encodeId=358420493310b, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Nov 28 12:15:55 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755698, encodeId=1c231e55698c0, content=<a href='/topic/show?id=b41f104424d' target=_blank style='color:#2F92EE;'>#KCNQ1OT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10442, encryptionId=b41f104424d, topicName=KCNQ1OT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2efd36990859, createdName=bbwuyu_015, createdTime=Thu Apr 15 05:15:55 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301934, encodeId=cfa7130193440, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 15 02:15:55 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005738, encodeId=70c52005e38d7, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Tue Aug 24 06:15:55 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1039991, encodeId=fded103999172, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Sep 13 14:15:55 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884923, encodeId=bb5f8849233c, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Sun Sep 13 11:33:24 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-12-29 cqlidoudou
  3. [GetPortalCommentsPageByObjectIdResponse(id=1739026, encodeId=acda1e3902614, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Dec 30 21:15:55 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649939, encodeId=b7881649939cd, content=<a href='/topic/show?id=69f810441ff' target=_blank style='color:#2F92EE;'>#KCNQ1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10441, encryptionId=69f810441ff, topicName=KCNQ1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ba23947018, createdName=cqlidoudou, createdTime=Tue Dec 29 03:15:55 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049331, encodeId=358420493310b, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Nov 28 12:15:55 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755698, encodeId=1c231e55698c0, content=<a href='/topic/show?id=b41f104424d' target=_blank style='color:#2F92EE;'>#KCNQ1OT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10442, encryptionId=b41f104424d, topicName=KCNQ1OT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2efd36990859, createdName=bbwuyu_015, createdTime=Thu Apr 15 05:15:55 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301934, encodeId=cfa7130193440, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 15 02:15:55 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005738, encodeId=70c52005e38d7, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Tue Aug 24 06:15:55 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1039991, encodeId=fded103999172, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Sep 13 14:15:55 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884923, encodeId=bb5f8849233c, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Sun Sep 13 11:33:24 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-11-28 cy0324
  4. [GetPortalCommentsPageByObjectIdResponse(id=1739026, encodeId=acda1e3902614, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Dec 30 21:15:55 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649939, encodeId=b7881649939cd, content=<a href='/topic/show?id=69f810441ff' target=_blank style='color:#2F92EE;'>#KCNQ1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10441, encryptionId=69f810441ff, topicName=KCNQ1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ba23947018, createdName=cqlidoudou, createdTime=Tue Dec 29 03:15:55 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049331, encodeId=358420493310b, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Nov 28 12:15:55 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755698, encodeId=1c231e55698c0, content=<a href='/topic/show?id=b41f104424d' target=_blank style='color:#2F92EE;'>#KCNQ1OT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10442, encryptionId=b41f104424d, topicName=KCNQ1OT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2efd36990859, createdName=bbwuyu_015, createdTime=Thu Apr 15 05:15:55 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301934, encodeId=cfa7130193440, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 15 02:15:55 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005738, encodeId=70c52005e38d7, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Tue Aug 24 06:15:55 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1039991, encodeId=fded103999172, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Sep 13 14:15:55 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884923, encodeId=bb5f8849233c, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Sun Sep 13 11:33:24 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1739026, encodeId=acda1e3902614, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Dec 30 21:15:55 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649939, encodeId=b7881649939cd, content=<a href='/topic/show?id=69f810441ff' target=_blank style='color:#2F92EE;'>#KCNQ1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10441, encryptionId=69f810441ff, topicName=KCNQ1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ba23947018, createdName=cqlidoudou, createdTime=Tue Dec 29 03:15:55 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049331, encodeId=358420493310b, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Nov 28 12:15:55 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755698, encodeId=1c231e55698c0, content=<a href='/topic/show?id=b41f104424d' target=_blank style='color:#2F92EE;'>#KCNQ1OT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10442, encryptionId=b41f104424d, topicName=KCNQ1OT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2efd36990859, createdName=bbwuyu_015, createdTime=Thu Apr 15 05:15:55 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301934, encodeId=cfa7130193440, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 15 02:15:55 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005738, encodeId=70c52005e38d7, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Tue Aug 24 06:15:55 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1039991, encodeId=fded103999172, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Sep 13 14:15:55 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884923, encodeId=bb5f8849233c, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Sun Sep 13 11:33:24 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-09-15 xzw113
  6. [GetPortalCommentsPageByObjectIdResponse(id=1739026, encodeId=acda1e3902614, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Dec 30 21:15:55 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649939, encodeId=b7881649939cd, content=<a href='/topic/show?id=69f810441ff' target=_blank style='color:#2F92EE;'>#KCNQ1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10441, encryptionId=69f810441ff, topicName=KCNQ1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ba23947018, createdName=cqlidoudou, createdTime=Tue Dec 29 03:15:55 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049331, encodeId=358420493310b, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Nov 28 12:15:55 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755698, encodeId=1c231e55698c0, content=<a href='/topic/show?id=b41f104424d' target=_blank style='color:#2F92EE;'>#KCNQ1OT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10442, encryptionId=b41f104424d, topicName=KCNQ1OT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2efd36990859, createdName=bbwuyu_015, createdTime=Thu Apr 15 05:15:55 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301934, encodeId=cfa7130193440, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 15 02:15:55 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005738, encodeId=70c52005e38d7, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Tue Aug 24 06:15:55 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1039991, encodeId=fded103999172, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Sep 13 14:15:55 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884923, encodeId=bb5f8849233c, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Sun Sep 13 11:33:24 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1739026, encodeId=acda1e3902614, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Dec 30 21:15:55 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649939, encodeId=b7881649939cd, content=<a href='/topic/show?id=69f810441ff' target=_blank style='color:#2F92EE;'>#KCNQ1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10441, encryptionId=69f810441ff, topicName=KCNQ1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ba23947018, createdName=cqlidoudou, createdTime=Tue Dec 29 03:15:55 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049331, encodeId=358420493310b, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Nov 28 12:15:55 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755698, encodeId=1c231e55698c0, content=<a href='/topic/show?id=b41f104424d' target=_blank style='color:#2F92EE;'>#KCNQ1OT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10442, encryptionId=b41f104424d, topicName=KCNQ1OT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2efd36990859, createdName=bbwuyu_015, createdTime=Thu Apr 15 05:15:55 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301934, encodeId=cfa7130193440, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 15 02:15:55 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005738, encodeId=70c52005e38d7, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Tue Aug 24 06:15:55 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1039991, encodeId=fded103999172, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Sep 13 14:15:55 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884923, encodeId=bb5f8849233c, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Sun Sep 13 11:33:24 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-09-13 留走人康

    膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1739026, encodeId=acda1e3902614, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6913, encryptionId=6e566913df, topicName=ERA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e36234488643, createdName=124988c7m106暂无昵称, createdTime=Wed Dec 30 21:15:55 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1649939, encodeId=b7881649939cd, content=<a href='/topic/show?id=69f810441ff' target=_blank style='color:#2F92EE;'>#KCNQ1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10441, encryptionId=69f810441ff, topicName=KCNQ1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4ba23947018, createdName=cqlidoudou, createdTime=Tue Dec 29 03:15:55 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2049331, encodeId=358420493310b, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Nov 28 12:15:55 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755698, encodeId=1c231e55698c0, content=<a href='/topic/show?id=b41f104424d' target=_blank style='color:#2F92EE;'>#KCNQ1OT1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10442, encryptionId=b41f104424d, topicName=KCNQ1OT1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2efd36990859, createdName=bbwuyu_015, createdTime=Thu Apr 15 05:15:55 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301934, encodeId=cfa7130193440, content=<a href='/topic/show?id=b469109e41d' target=_blank style='color:#2F92EE;'>#lncRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10974, encryptionId=b469109e41d, topicName=lncRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Tue Sep 15 02:15:55 CST 2020, time=2020-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005738, encodeId=70c52005e38d7, content=<a href='/topic/show?id=6ff1525e13' target=_blank style='color:#2F92EE;'>#CRN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5257, encryptionId=6ff1525e13, topicName=CRN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Tue Aug 24 06:15:55 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1039991, encodeId=fded103999172, content=膀胱癌真怪,明明是免疫敏感性肿瘤,为什么PD-1治疗效果不好呢?难道靶点不对?将来CD47会不会有效, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Sep 13 14:15:55 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884923, encodeId=bb5f8849233c, content=学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f435296195, createdName=ms3000000449926787, createdTime=Sun Sep 13 11:33:24 CST 2020, time=2020-09-13, status=1, ipAttribution=)]
    2020-09-13 ms3000000449926787

    学习一下

    0

相关资讯

Eur Urol:局部晚期和转移性尿道癌中成纤维细胞生长因子受体3的变异状态与对铂化疗敏感性的差异相关

在大约15%的肌层侵袭性膀胱癌(MIBCs)和转移性尿道肿瘤(mUCs)中,成纤维细胞生长因子受体3(FGFR3)存在变异。最近,有研究人员在MIBC或者mUC患者中确定了FGFR3状态与对铂化疗响应

Eur Urol:临床再分期和肿瘤测序时肌层浸润膀胱癌新辅助化疗的不准确指标

肌层浸润性膀胱癌(MIBC)患者的标准护理包括新辅助顺铂化疗(NAC),随后进行放化疗或根治性膀胱癌切除术(RC)的巩固治疗。一些患者进行NAC后发生了剧烈的病理反应,而这些已被报道与特定基因途径的体

膀胱癌药物治疗的临床进展

膀胱癌占我国泌尿生殖系肿瘤发病率的第一位,而在西方其发病率仅次于前列腺癌,居第2位。

Eur Urol:经尿道膀胱肿瘤切除术治疗非肌层浸润性膀胱癌质量和效果的改善

非肌层浸润性膀胱癌(NMIBC)的临床结果部分的由起始干预手段的质量来决定。最近,有研究人员评估了与经尿道膀胱肿瘤切除(TURBT)相关的特异性质量指标(QIs)的符合性情况,并了解在引入QPI(质量

盘点:近期膀胱研究盘点

膀胱是一个储尿器官。在哺乳类,它是由平滑肌组成的一个囊形结构,位于骨盆内,其后端开口与尿道相通。膀胱与尿道的交界处有括约肌,可以控制尿液的排出。膀胱为锥体形囊状肌性器官,位于小骨盆腔的前部。膀胱癌是指

Cell Death Discovery:一种检测膀胱癌尿液中肿瘤软骨素硫酸酯糖胺聚糖的简单方法

膀胱肿瘤中的蛋白多糖被一种独特的肿瘤软骨素硫酸酯(ofCS)糖胺多糖修饰,这种糖胺多糖通常仅限于胎盘滋养细胞。该ofCS修饰可以在膀胱肿瘤中通过疟疾VAR2CSA蛋白进行检测;另外,疟疾发病机制中,该